Ratings
0
Nobody has rated this yet. Be the first!
Works
9
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.
PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS
Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer
High frequency of allelic loss at the BRCA1 locus in ovarian cancers: clinicopathologic and molecular associations.
Loss of heterozygosity, microsatellite instability and TP53 gene status in ovarian carcinomas
Evaluating the ovarian cancer gonadotropin hypothesis: a candidate gene study
Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk
Germline SMARCA4 mutations in patients with ovarian small cell carcinoma of hypercalcemic type
Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer
